Analytical Data
-
基因名
ICT1
- Application
-
别名
MRPL58;DS1;ICT1;Large ribosomal subunit Protein mL62
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q14197
-
表达区间
30-206aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSLHKQKDG TEFKSIYSLD KLYPESQGSD TAWRVPNGAK QADSDIPLDR LTISYCRSSG PGGQNVNKVN SKAEVRFHLA TAEWIAEPVR QKIAITHKNK INRLGELILT SESSRYQFRN LADCLQKIRD MITEASQTPK EPTKEDVKLH RIRIENMNRE RLRQKRIHSA VKTSRRVDMD
-
分子量
23 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on ICT1 recombinant protein is driven by its significant role in various biological processes and potential applications in biotechnology and medicine. ICT1, or InterCellular Transcription factor 1, is a crucial protein involved in the regulation of gene expression, particularly in the context of cellular stress responses and developmental processes. Understanding its structure and function can provide insights into the molecular mechanisms underlying critical cellular activities. Additionally, ICT1 has been implicated in various diseases, including cancer and neurodegenerative disorders, making it a potential target for therapeutic interventions. By employing recombinant DNA technology, researchers can produce ICT1 in heterologous systems to elucidate its functional properties, enabling the study of its interactions with other cellular components and the development of inhibitors or modulators. This research not only aims to enhance the understanding of ICT1's biological roles but also to explore its utility in clinical settings, such as drug development and disease modeling. As the exploration of ICT1 advances, it promises to contribute significantly to the broader field of molecular biology and therapeutic innovation.
